Utah Medical Products, Inc. (UTMD) Profit Margins
Over the twelve months to 2026-06-30, Utah Medical Products, Inc. (UTMD) had gross margin 57.9%, operating margin 28.4%, net margin 29.0%, free cash flow margin 31.7%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
UTMDUtah Medical Products, Inc.Follow UTMD — free
—
Price chart with a free account
- Market cap
- 236.3M
- P/E TTM
- 22.6
- Dividend yield
- 1.7%
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 59.2% | 60.9% | 59.9% | 60.5% | 60.2% | 60.3% | 63.7% | 62.6% | 62.8% | 60.6% | 63.0% | 61.6% | 59.8% | 59.0% | 57.1% | 57.9% | |
| Operating margin | 31.3% | 36.6% | 36.6% | 39.3% | 39.0% | 41.2% | 45.9% | 44.5% | 37.6% | 32.5% | 38.5% | 37.9% | 33.4% | 33.2% | 29.6% | 28.4% | |
| Net margin | 19.6% | 24.5% | 28.2% | 27.6% | 29.5% | 30.9% | 20.5% | 44.2% | 31.4% | 25.6% | 30.1% | 31.5% | 33.1% | 33.9% | 29.3% | 29.0% | |
| FCF margin | 29.4% | 32.0% | 29.6% | 34.6% | 33.9% | 28.6% | 37.0% | 39.1% | 35.2% | 45.7% | 42.1% | 38.9% | 43.1% | 35.7% | 37.2% | 31.7% |
USD millions · SEC XBRL
Utah Medical Products, Inc. — questions
- What is Utah Medical Products, Inc.'s gross margin?
- 57.9% over the twelve months to 2026-06-30.
- What is Utah Medical Products, Inc.'s operating margin?
- 28.4% over the twelve months to 2026-06-30.
- What is Utah Medical Products, Inc.'s net profit margin?
- 29.0% over the twelve months to 2026-06-30.
Every figure on this page comes from Utah Medical Products, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.